| Dr Brian Keith Nadolne, MD | |
|
1121 Johnson Ferry Rd Ste 320, Marietta, GA 30068-5404 | |
| (770) 509-0017 | |
| (770) 971-7818 |
| Full Name | Dr Brian Keith Nadolne |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 1121 Johnson Ferry Rd Ste 320, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407805872 | NPI | - | NPPES |
| 5656896 | Other | GA | CIGNA |
| 7394560 | Other | GA | AETNA |
| 000739505E | Medicaid | GA | |
| 52543664 | Other | GA | B/C B/S OF GEORGIA |
| 1073451 | Other | GA | COVENTRY HEALTHCARE |
| 176614008 | Other | GA | UNITED HEALTHCARE |
| P00243653 | Other | GA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 040748 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northside Primary Care Professional Services,llc | 9638343924 | 262 |
| Northside Urgent Care Holding Llc | 4587984695 | 61 |
News Archive
The Biotechnology Industry Organization (BIO) commends the House of Representatives for including provisions intended to ease small business regulatory burdens as part of the Wall Street Reform and Consumer Protection Act of 2009 (H.R. 4173) which passed today.
The National Academy of Sciences' Institute of Medicine released a report recommending nutrition standards be established for "competitive" foods in the school environment, such as a la carte cafeteria items, vending machines and school stores.
The Melanoma Network of Canada is excited with the new hope that long-anticipated results of a late-stage skin cancer trial brings to patients with advanced melanoma. The results, presented at the American Society of Clinical Oncology annual meeting, show increased survival with the experimental treatment ipilimumab in patients with previously-treated metastatic melanoma, the most deadly form of skin cancer.
Biothreats - harmful pathogens that are either naturally or deliberately released - pose a risk to national security and public health, and identifying new detection methods is a top priority for the Department of Homeland Security (DHS) Science and Technology Directorate.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
› Verified 8 days ago
| Entity Name | Northside Primary Care Professional Services,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922397553 PECOS PAC ID: 9638343924 Enrollment ID: O20111123000206 |
News Archive
The Biotechnology Industry Organization (BIO) commends the House of Representatives for including provisions intended to ease small business regulatory burdens as part of the Wall Street Reform and Consumer Protection Act of 2009 (H.R. 4173) which passed today.
The National Academy of Sciences' Institute of Medicine released a report recommending nutrition standards be established for "competitive" foods in the school environment, such as a la carte cafeteria items, vending machines and school stores.
The Melanoma Network of Canada is excited with the new hope that long-anticipated results of a late-stage skin cancer trial brings to patients with advanced melanoma. The results, presented at the American Society of Clinical Oncology annual meeting, show increased survival with the experimental treatment ipilimumab in patients with previously-treated metastatic melanoma, the most deadly form of skin cancer.
Biothreats - harmful pathogens that are either naturally or deliberately released - pose a risk to national security and public health, and identifying new detection methods is a top priority for the Department of Homeland Security (DHS) Science and Technology Directorate.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
› Verified 8 days ago
| Entity Name | Northside Urgent Care Holding Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679962237 PECOS PAC ID: 4587984695 Enrollment ID: O20150513000795 |
News Archive
The Biotechnology Industry Organization (BIO) commends the House of Representatives for including provisions intended to ease small business regulatory burdens as part of the Wall Street Reform and Consumer Protection Act of 2009 (H.R. 4173) which passed today.
The National Academy of Sciences' Institute of Medicine released a report recommending nutrition standards be established for "competitive" foods in the school environment, such as a la carte cafeteria items, vending machines and school stores.
The Melanoma Network of Canada is excited with the new hope that long-anticipated results of a late-stage skin cancer trial brings to patients with advanced melanoma. The results, presented at the American Society of Clinical Oncology annual meeting, show increased survival with the experimental treatment ipilimumab in patients with previously-treated metastatic melanoma, the most deadly form of skin cancer.
Biothreats - harmful pathogens that are either naturally or deliberately released - pose a risk to national security and public health, and identifying new detection methods is a top priority for the Department of Homeland Security (DHS) Science and Technology Directorate.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Keith Nadolne, MD 1230 Johnson Ferry Pl, Ste B-10, Marietta, GA 30068-2048 Ph: (770) 509-0017 | Dr Brian Keith Nadolne, MD 1121 Johnson Ferry Rd Ste 320, Marietta, GA 30068-5404 Ph: (770) 509-0017 |
News Archive
The Biotechnology Industry Organization (BIO) commends the House of Representatives for including provisions intended to ease small business regulatory burdens as part of the Wall Street Reform and Consumer Protection Act of 2009 (H.R. 4173) which passed today.
The National Academy of Sciences' Institute of Medicine released a report recommending nutrition standards be established for "competitive" foods in the school environment, such as a la carte cafeteria items, vending machines and school stores.
The Melanoma Network of Canada is excited with the new hope that long-anticipated results of a late-stage skin cancer trial brings to patients with advanced melanoma. The results, presented at the American Society of Clinical Oncology annual meeting, show increased survival with the experimental treatment ipilimumab in patients with previously-treated metastatic melanoma, the most deadly form of skin cancer.
Biothreats - harmful pathogens that are either naturally or deliberately released - pose a risk to national security and public health, and identifying new detection methods is a top priority for the Department of Homeland Security (DHS) Science and Technology Directorate.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
› Verified 8 days ago
Dr. Yen-i Grace Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 Johnson Ferry Rd, Marietta, GA 30068 Phone: 770-579-7900 Fax: 770-579-7942 | |
Neety Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3707 Largent Way Nw, Marietta, GA 30064 Phone: 678-581-5830 Fax: 678-581-5835 | |
Jamin Graham, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-793-5000 | |
Dr. Philip Batista, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Johnson Ferry Rd, Marietta, GA 30068 Phone: 770-579-7900 Fax: 770-579-7932 | |
Dr. Harvey David Braunfeld, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 299 Pat Mell Rd Se, Marietta, GA 30060 Phone: 770-432-5500 Fax: 770-431-8363 | |
William Edward Snell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 880 Canton Rd Ne, Suite 300, Marietta, GA 30060 Phone: 770-590-0585 Fax: 770-428-4087 | |
Dr. Miles Eli Brett, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2520 Windy Hill Rd Se, Suite 301, Marietta, GA 30067 Phone: 770-952-1032 Fax: 770-952-8579 |